These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22674103)

  • 21. [Efficacy of thalidomide in digestive bleeding caused by angiodysplasias].
    Fernández Salazar LI; Velayos Jiménez B; Fernández Galante I; Aller de la Fuente R; González Hernández JM
    Rev Esp Enferm Dig; 2009 May; 101(5):371. PubMed ID: 19527086
    [No Abstract]   [Full Text] [Related]  

  • 22. Thalidomide for the treatment of severe intestinal bleeding.
    Alberto SF; Felix J; de Deus J
    Endoscopy; 2008 Sep; 40(9):788; author reply 789. PubMed ID: 18773348
    [No Abstract]   [Full Text] [Related]  

  • 23. Thalidomide for the treatment of chronic gastrointestinal bleeding from angiodysplasias: a case series.
    Kamalaporn P; Saravanan R; Cirocco M; May G; Kortan P; Kandel G; Marcon N
    Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1347-50. PubMed ID: 19730385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thalidomide for treatment of bleeding angiodysplasias during hemodialysis.
    Mimidis K; Kaliontzidou M; Tzimas T; Papadopoulos V
    Ren Fail; 2008; 30(10):1040-1. PubMed ID: 19016158
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful Treatment of Recurrent Gastrointestinal Bleeding Due to Small Intestine Angiodysplasia and Multiple Myeloma with Thalidomide: Two Birds with One Stone.
    Hude I; Batinić J; Kinda SB; Pulanić D
    Turk J Haematol; 2018 Nov; 35(4):305-306. PubMed ID: 29911985
    [No Abstract]   [Full Text] [Related]  

  • 26. Somatostatin analogues for bleeding gastrointestinal angiodysplasias: when should thalidomide be prescribed?
    Molina-Infante J; Perez-Gallardo B
    Dig Dis Sci; 2011 Jan; 56(1):266-7. PubMed ID: 21046246
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of multiple small bowel angiodysplasias causing severe life-threatening bleeding with thalidomide.
    Kirkham SE; Lindley KJ; Elawad MA; Blanshard C; Shah N
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):585-7. PubMed ID: 16707986
    [No Abstract]   [Full Text] [Related]  

  • 28. Is thalidomide effective for the treatment of gastrointestinal bleeding in hereditary hemorrhagic telangiectasia?
    Pérez-Encinas M; Rabuñal Martínez MJ; Bello López JL
    Haematologica; 2002 Aug; 87(8):ELT34. PubMed ID: 12161379
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical features and treatment of hereditary hemorrhagic telangiectasia.
    Li S; Wang SJ; Zhao YQ
    Medicine (Baltimore); 2018 Aug; 97(31):e11687. PubMed ID: 30075565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macroscopic appearance of intestinal angiodysplasias under antiangiogenic treatment with thalidomide.
    Bauditz J; Lochs H; Voderholzer W
    Endoscopy; 2006 Oct; 38(10):1036-9. PubMed ID: 17058171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Invalidating and recurrent gastrointestinal bleeding caused by intestinal angiodysplasia: treatment with thalidomide].
    Serralta de Colsa D; Arjona Medina I; García Marín A; Sanz Sánchez M; Turégano Fuentes F
    Rev Esp Enferm Dig; 2008 May; 100(5):306-7. PubMed ID: 18662087
    [No Abstract]   [Full Text] [Related]  

  • 32. Hereditary Hemorrhagic Telangiectasia.
    Parambil JG
    Clin Chest Med; 2016 Sep; 37(3):513-21. PubMed ID: 27514597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary arteriovenous malformations etiologies in HHT patients and potential utility of thalidomide.
    Lacout A; Marcy PY; El Hajjam M; Lacombe P
    Med Hypotheses; 2013 May; 80(5):587-8. PubMed ID: 23452644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic failure with thalidomide in patients with recurrent intestinal bleeding due to angiodysplasias.
    Izquierdo Navarro Mdel C; Hernando Verdugo M; Cardaba Garcia E; Sanchez Sanchez MT
    Farm Hosp; 2016 May; 40(3):230-2. PubMed ID: 27145393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thalidomide for treatment of gastrointestinal bleedings due to angiodysplasia: a case report in acquired von Willebrand syndrome and review of the literature.
    Engelen ET; van Galen KP; Schutgens RE
    Haemophilia; 2015 Jul; 21(4):419-29. PubMed ID: 25929157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beneficial effects and reversion of vascular lesions by thalidomide in a patient with bleeding portal hypertensive enteropathy.
    Jimenez-Saenz M; Romero-Vazquez J; Caunedo-Alvarez A; Maldonado-Perez B; Gutierrez JM
    Dig Liver Dis; 2010 Mar; 42(3):232-3. PubMed ID: 19574114
    [No Abstract]   [Full Text] [Related]  

  • 37. A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT).
    Zarrabeitia R; Albiñana V; Salcedo M; Señaris-Gonzalez B; Fernandez-Forcelledo JL; Botella LM
    Curr Vasc Pharmacol; 2010 Jul; 8(4):473-81. PubMed ID: 19485912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life.
    Baysal M; Ümit EG; Kırkızlar HO; Özdöver AC; Demir AM
    Turk J Haematol; 2019 Feb; 36(1):43-47. PubMed ID: 29880465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary hemorrhagic telangiectasia with liver cirrhosis: a case report.
    Xu L; Xu F; Wang Q; Ke X
    BMC Gastroenterol; 2021 Sep; 21(1):343. PubMed ID: 34488642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aflibercept for Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia: A Case Report.
    Villanueva B; Iriarte A; Torres-Iglesias R; Muñoz Bolaño M; Cerdà P; Riera-Mestre A
    Medicina (Kaunas); 2023 Aug; 59(9):. PubMed ID: 37763652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.